Insider · CIK 0000943431
Joshua Ruch
director
Files at WGS (GeneDx Holdings Corp.). First filing Nov 26, 2025, latest Nov 26, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $6.1M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
WGS: GeneDx Holdings Corp.
WGSOct 9, 2026 · close 67.33
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 68Notable | GeneDx Holdings Corp. | $6.1M 38,000 shares | -256% | +186% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: Kariba LLC | -201 | $158.40 | $32k | 14,644 | Nov 26, 2025 |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: Kariba LLC | -625 | $159.28 | $100k | 14,019 | Nov 26, 2025 |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: Kariba LLC | -889 | $160.45 | $143k | 13,130 | Nov 26, 2025 |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: Kariba LLC | -1,117 | $161.16 | $180k | 12,013 | Nov 26, 2025 |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: Kariba LLC | -72 | $162.04 | $12k | 11,941 | Nov 26, 2025 |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: Rugu2 LLC | -407 | $158.40 | $64k | 29,731 | Nov 26, 2025 |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: Rugu2 LLC | -1,268 | $159.28 | $202k | 28,463 | Nov 26, 2025 |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: Rugu2 LLC | -1,805 | $160.45 | $290k | 26,658 | Nov 26, 2025 |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: Rugu2 LLC | -2,268 | $161.16 | $366k | 24,390 | Nov 26, 2025 |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: Rugu2 LLC | -147 | $162.04 | $24k | 24,243 | Nov 26, 2025 |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: VAAL Investment Partners Q9 LP | -2,016 | $158.40 | $319k | 147,268 | Nov 26, 2025 |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: VAAL Investment Partners Q9 LP | -6,279 | $159.28 | $1.0M | 140,989 | Nov 26, 2025 |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: VAAL Investment Partners Q9 LP | -8,944 | $160.45 | $1.4M | 132,045 | Nov 26, 2025 |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: VAAL Investment Partners Q9 LP | -11,234 | $161.16 | $1.8M | 120,811 | Nov 26, 2025 |
| Nov 24, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stockindirect: VAAL Investment Partners Q9 LP | -728 | $162.04 | $118k | 120,083 | Nov 26, 2025 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +12,924 | $0.00 | $0 | 29,723 | Jun 23, 2025 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | +3,576 | $0.00 | $0 | 3,576 | Jun 23, 2025 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -12,924 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Feb 5, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +5,816 | $7.89 | $46k | 16,799 | Feb 7, 2025 |
| Feb 5, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Stock Option (right to buy)derivative | -5,816 | $0.00 | $0 | 0 | Feb 7, 2025 |
| Jan 17, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +3,000 | $7.89 | $24k | 10,983 | Jan 22, 2025 |
| Jan 17, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Stock Option (right to buy)derivative | -3,000 | $0.00 | $0 | 5,816 | Jan 22, 2025 |
| Oct 15, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +130 | - | - | 7,983 | Oct 17, 2024 |
| Oct 15, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -130 | $0.00 | $0 | 0 | Oct 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.